Cytek Biosciences Files Q1 2025 10-Q
Ticker: CTKB · Form: 10-Q · Filed: May 8, 2025 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Cytek Q1 2025 10-Q filed. Financials updated.
AI Summary
Cytek Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Fremont, CA, reported financial data for the first quarter of 2025. Key financial figures and operational details are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Cytek Biosciences, Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing financial information and does not inherently present new risks.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Filer of the 10-Q
- Fremont, CA (location) — Business and mailing address
- 20250331 (date) — Period of report
- 20250508 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20250508.
What is the company's Central Index Key (CIK)?
The company's Central Index Key is 0001831915.
Where is Cytek Biosciences, Inc. located?
The company's business and mailing address is 47215 Lakeview Boulevard, Fremont, CA 94538.
What is the Standard Industrial Classification (SIC) code for Cytek Biosciences, Inc.?
The SIC code is 3826, which corresponds to Laboratory Analytical Instruments.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Cytek Biosciences, Inc. (CTKB).